Stability of standardized uptake values for quantitative bone SPECT for jawbone lesions: a single-center cross-sectional study

Abstract Background The long time required for bone uptake of radiopharmaceutical material after injection for bone scintigraphy is a burden for patients with poor health. Thus, to assess whether the uptake time could be reduced for single-photon emission computed tomography (SPECT) of the jawbone,...

Full description

Saved in:
Bibliographic Details
Main Authors: Hironobu Hata (Author), Satoshi Shimomura (Author), Kenji Imamachi (Author), Jun Sato (Author), Takuya Asaka (Author), Kenji Hirata (Author), Kyousuke Funayama (Author), Yoichi Mori (Author), Masashi Matsuzaka (Author), Toshikazu Nambu (Author), Yoshimasa Kitagawa (Author)
Format: Book
Published: BMC, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8a411c5b75a443e2ac319f96c63c6fb1
042 |a dc 
100 1 0 |a Hironobu Hata  |e author 
700 1 0 |a Satoshi Shimomura  |e author 
700 1 0 |a Kenji Imamachi  |e author 
700 1 0 |a Jun Sato  |e author 
700 1 0 |a Takuya Asaka  |e author 
700 1 0 |a Kenji Hirata  |e author 
700 1 0 |a Kyousuke Funayama  |e author 
700 1 0 |a Yoichi Mori  |e author 
700 1 0 |a Masashi Matsuzaka  |e author 
700 1 0 |a Toshikazu Nambu  |e author 
700 1 0 |a Yoshimasa Kitagawa  |e author 
245 0 0 |a Stability of standardized uptake values for quantitative bone SPECT for jawbone lesions: a single-center cross-sectional study 
260 |b BMC,   |c 2024-03-01T00:00:00Z. 
500 |a 10.1186/s12903-024-04067-2 
500 |a 1472-6831 
520 |a Abstract Background The long time required for bone uptake of radiopharmaceutical material after injection for bone scintigraphy is a burden for patients with poor health. Thus, to assess whether the uptake time could be reduced for single-photon emission computed tomography (SPECT) of the jawbone, this study evaluated differences in maximum standardized uptake values (SUVmax) within patients using SPECT imaging at 2 and 3 hours after radiopharmaceutical injection. Methods A total of 33 patients undergoing treatment or in post-treatment follow-up for medication-related osteonecrosis of the jaw, who visited our hospital between July 2020 and August 2021 and could receive SPECT twice on the same day, were enrolled in the study. Patients were injected with technetium-99 m hydroxymethylene diphosphonate (Tc-99 m HMDP) intravenously. The SUVmax for healthy parietal bones and jawbone lesions were calculated from the SPECT images using quantitative analysis software, and the SUVmax were compared between 2- and 3-hour uptake times. Results After exclusion, 30 patients were included in the study. In the 2-hour and 3-hour images, the median SUVmax of the parietal bones were 1.90 and 1.81, respectively, and those of the jawbone lesions were 9.25 and 9.39, respectively. The limits of agreement (LOA) ranged from − 0.33 to 0.25 in the parietal bones, and the %LOA ranged from − 9.8 to 17.3% in the jawbone lesions, showing high equivalence between the two uptake durations. The SUVmax showed no clinical differences between the 2- and 3-hour uptake durations for Tc-99 m HMDP SPECT of the jawbone. Conclusions The results of this study justify a 2-3-hour uptake window when performing quantitative SPECT of the jawbone. Therefore, the minimum uptake time can potentially be reduced to only 2 hours. 
546 |a EN 
690 |a SPECT 
690 |a Quantitative analysis 
690 |a MRONJ 
690 |a Uptake time 
690 |a Jawbone 
690 |a Dentistry 
690 |a RK1-715 
655 7 |a article  |2 local 
786 0 |n BMC Oral Health, Vol 24, Iss 1, Pp 1-10 (2024) 
787 0 |n https://doi.org/10.1186/s12903-024-04067-2 
787 0 |n https://doaj.org/toc/1472-6831 
856 4 1 |u https://doaj.org/article/8a411c5b75a443e2ac319f96c63c6fb1  |z Connect to this object online.